Takatani Rieko, Minagawa Masanori, Molinaro Angelo, Reyes Monica, Kinoshita Kaori, Takatani Tomozumi, Kazukawa Itsuro, Nagatsuma Misako, Kashimada Kenichi, Sato Kenichi, Matsushita Kazuyuki, Nomura Fumio, Shimojo Naoki, Jüppner Harald
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Endocrinology, Chiba Children's Hospital, Chiba, Japan.
Bone. 2015 Oct;79:15-20. doi: 10.1016/j.bone.2015.05.011. Epub 2015 May 19.
Pseudohypoparathyroidism type Ib (PHP1B) is caused by proximal tubular resistance to parathyroid hormone that occurs in most cases in the absence of Albright's Hereditary Osteodystrophy (AHO). Familial forms of PHP1B are caused by maternally inherited microdeletions within STX16, the gene encoding syntaxin 16, or within GNAS, a complex genetic locus on chromosome 20q13.3 encoding Gsα and several splice variants thereof. These deletions lead either to a loss-of-methylation affecting GNAS exon A/B alone or to epigenetic changes involving multiple differentially methylated regions (DMRs) within GNAS. Broad GNAS methylation abnormalities are also observed in most sporadic PHP1B (sporPHP1B) cases. However, with the exception of paternal uniparental disomy involving chromosome 20q (patUPD20q), the molecular mechanism leading to this disease variant remains unknown. We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated PTH levels, and occasionally with TSH elevations and mild AHO features. Age at diagnosis was 10.6 ± 1.45 years. Calcium, phosphate, and PTH were 6.3 ± 0.23 mg/dL, 7.7 ± 0.33 mg/dL, and 305 ± 34.5 pg/mL, respectively, i.e. laboratory findings that are indistinguishable from those previously observed for Caucasian sporPHP1B cases. All investigated patients showed broad GNAS methylation changes. Eleven individuals were homozygous for SNPs within exon NESP and a pentanucleotide repeat in exon A/B. Two of these patients furthermore revealed homozygosity for numerous microsatellite markers on chromosome 20q raising the possibility of patUPD20q, which was confirmed through the analysis of parental DNA. Based on this and our previous reports, paternal duplication of the chromosomal region comprising the GNAS locus appears to be a fairly common cause of sporPHP1B that is likely to occur with equal frequency in Caucasians and Asians.
I型假性甲状旁腺功能减退症(PHP1B)是由近端肾小管对甲状旁腺激素产生抵抗所致,多数情况下发生时并无Albright遗传性骨营养不良(AHO)。PHP1B的家族形式是由母系遗传的STX16(编码 syntaxin 16的基因)或GNAS(位于20号染色体q13.3上的一个复杂基因座,编码Gsα及其几种剪接变体)内的微缺失引起。这些缺失要么导致仅影响GNAS外显子A/B的甲基化缺失,要么导致涉及GNAS内多个差异甲基化区域(DMR)的表观遗传变化。在大多数散发性PHP1B(sporPHP1B)病例中也观察到广泛的GNAS甲基化异常。然而,除了涉及20号染色体q的父源单亲二倍体(patUPD20q)外,导致这种疾病变体的分子机制仍然未知。我们现在研究了23例日本sporPHP1B病例,这些病例表现为低钙血症、高磷血症、甲状旁腺激素水平升高,偶尔伴有促甲状腺激素升高和轻度AHO特征。诊断时的年龄为10.6±1.45岁。钙、磷和甲状旁腺激素水平分别为6.3±0.23mg/dL、7.7±0.33mg/dL和305±34.5pg/mL,即这些实验室检查结果与之前观察到的白种人sporPHP1B病例的结果无法区分。所有研究患者均表现出广泛的GNAS甲基化变化。11名个体在外显子NESP内的单核苷酸多态性(SNP)和外显子A/B中的五核苷酸重复上是纯合的。其中两名患者在20号染色体q上的众多微卫星标记上也显示为纯合,这增加了patUPD20q的可能性,通过对父母DNA的分析得以证实。基于此以及我们之前的报告,包含GNAS基因座的染色体区域的父源重复似乎是sporPHP1B相当常见的病因,在白种人和亚洲人中发生的频率可能相同。